Deals
33 today · ranked by importance and coverage
- IAF chief A.P. Singh says the MRFA deal could be finalised this financial year
- Russia’s Su-57 is among options if the AMCA programme faces delays
- The fighter procurement outlook matters to Indian defence companies competing for contracts
- GPT Infra arm Alcon Builders was declared L1 bidder for a ₹149.49 crore Western Railway project
- Work covers signalling and telecom equipment at 18 stations
- A potential railway order could support GPT Infraprojects’ project pipeline
- Cube Highways Trust raised ₹1,150 crore through senior secured NCDs
- The AAA-rated NCDs carry a 7.50% annual coupon
- The fundraising adds debt capital to Indian highway assets, relevant to roads and infrastructure investors
- David Ellison announced the combined company will be named Skydance
- The announcement came less than two weeks after Paramount settled an antitrust lawsuit
- Brookfield and Apollo are investing in Europe’s hostel market
- Hostels have been a long-ignored corner of the travel industry
- L&T is in talks with Itochu on equity participation in its clean energy arm
- L&T is also pursuing a green ammonia offtake and Kandla as an export hub
- A potential clean-energy stake sale and ammonia exports expose L&T investors to the project’s progress
- Indian startups raised over $233 Mn in the final week of September
- Funding momentum continued across homegrown new-age tech ventures
●
- Hindalco scrapped its planned acquisition of US-based speciality alumina maker AluChem
- The company said the deal’s termination does not change its high-value products strategy
- The abandoned deal removes acquisition uncertainty for Hindalco, while its specialty-products expansion strategy remains intact
- Granules India incorporated Triton Farmaceutica Do Brasil Ltda as a wholly owned subsidiary in Brazil
- The subsidiary will manufacture, promote, sell and distribute pharmaceuticals and related products in Brazil
- Brazil expansion gives Granules India a new market for its pharmaceutical business
- The fund will use secured debt to finance real estate ventures
- It will focus on projects in Delhi-NCR and West Bengal
- The fund adds financing for real estate projects in Delhi-NCR and West Bengal
- GP Petroleums will raise ₹130 crore from RevX fund to finance expansion
- The board-approved funding includes ₹30 crore in 36-month NCDs and ₹100 crore in optionally convertible debentures
- Expansion funding and potential dilution affect GP Petroleums shareholders
- Indian start-ups are being acquired 2X faster as incumbents seek capabilities
- Average time from first funding to IPO fell from 14 years to 8.5 years
- Faster exits may benefit Indian startup investors and listed companies seeking new capabilities
- Abogen will receive $575 million upfront and up to $7.2 billion in milestone payments
- Milestones depend on clinical development, approvals and commercial milestones
- The deal highlights global pharma licensing activity, with limited direct read-through for Indian drugmakers
- SBI bought nearly ₹5,000 crore, or about 40%, of Reliance Industries’ ₹13,000 crore bond issue
- SBI’s large subscription signals demand for Reliance Industries debt and affects PSU bank exposure
●
- Adani’s Maharashtra investment commitment exceeds ₹6 lakh crore across multiple sectors
- Projects worth ₹2.6 lakh crore are completed or underway, about 43% of the blueprint
- The investment pipeline puts Adani’s energy, aviation and infrastructure businesses in focus
- The planned investment is ₹6,000 crore for a C-390 assembly line in Nagpur
- The facility depends on the Indian Air Force selecting the C-390 and a government order
- A potential boost for Mahindra and India’s defence manufacturing supply chain, contingent on an IAF contract
- Western biopharma companies are increasingly turning to China to source drug innovation
- The shift comes as pharma's patent cliff draws closer
●
- Greer said Modi and Trump had a “constructive call yesterday morning”; another call may follow soon
- Greer said sticking points remain and he did not think a deal was imminent
- Goyal pushed for an early interim deal to keep Indian exporters competitive in the US market
- A delayed deal leaves Indian exporters facing continued uncertainty over access and competitiveness in the US market
That’s everything for today
